Report for Molnar J

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Phase 1 and pre-clinical profiling of ESM-HDAC391, a myeloid-targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia - Furze_2022_Br.J.Clin.Pharmacol__
Author(s) : Furze RC , Molnar J , Parr NJ , Ahmad F , Henry Y , Howe D , Singh R , Toal M , Bassil AK , Bernard SG , Davis RP , Gibson A , Maller NC , Sharp C , Tough DF , Prinjha RK , Lewis HD
Ref : British Journal of Clinical Pharmacology , : , 2022
Abstract : Furze_2022_Br.J.Clin.Pharmacol__
ESTHER : Furze_2022_Br.J.Clin.Pharmacol__
PubMedSearch : Furze_2022_Br.J.Clin.Pharmacol__
PubMedID: 35655123

Title : Occupational exposure to organophosphorus insecticides and synthetic pyrethroid - Adamis_1985_Int.Arch.Occup.Environ.Health_56_299
Author(s) : Adamis Z , Antal A , Fuzesi I , Molnar J , Nagy L , Susan M
Ref : Int Arch Occup Environ Health , 56 :299 , 1985
Abstract : Adamis_1985_Int.Arch.Occup.Environ.Health_56_299
ESTHER : Adamis_1985_Int.Arch.Occup.Environ.Health_56_299
PubMedSearch : Adamis_1985_Int.Arch.Occup.Environ.Health_56_299
PubMedID: 4066053